Sertraline and Ardeparin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordArdeparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Let's talk about taking sertraline (an antidepressant) together with ardeparin (a blood thinner given as an injection). Each one can make it a little easier to bleed. Sertraline affects a chemical called serotonin that your platelets use to help form clots, and ardeparin thins your blood directly. Put together, they can add up and raise your chance of bruising or bleeding.
Watch for things like nosebleeds, easy bruising, or bleeding that is hard to stop. The good news is that this is very manageable. Keep taking both exactly as prescribed, and let your care team know you take them so they can watch you closely.
Effect: Additive increased bleeding risk with concurrent sertraline and ardeparin (LMWH).
- Mechanism (PD): SSRIs deplete platelet serotonin, impairing platelet aggregation; ardeparin provides direct anticoagulation. Effects on hemostasis are additive. Neither agent's activation is enzyme-dependent here, so this is a pharmacodynamic, not PK, interaction.
- Direction: Enhanced bleeding effect.
- Onset: Delayed. Evidence: Probable (case-control and cohort data). Severity: Major.
- Management: Monitor for bleeding (epistaxis, ecchymosis, hematoma, petechiae, GI or intracranial hemorrhage); counsel patient on bleeding signs. Individualize therapy and monitor more closely as needed.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients about the elevated bleeding risk.1. Hemostasis depends in part on platelets releasing serotonin. Studies using case-control and cohort designs have demonstrated that taking SSRIs (for example, sertraline) alongside anticoagulants carries an association with a greater bleeding risk 231. Using sertraline at the same time as an anticoagulant can amplify the likelihood of bleeding. Among the bleeding events that have been documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
Your care team can manage this combination safely with awareness and monitoring.
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Your team may monitor you more closely for bleeding, and your doses may be adjusted and individualized as needed.
- Watch for and promptly report: nosebleeds, unusual bruising, blood in urine or stool, black stools, coughing or vomiting blood, or bleeding that will not stop.
- Seek urgent care for severe headache, dizziness, or heavy bleeding.
Tell every pharmacist and prescriber that you take both medicines so they can keep an eye on this.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported a higher risk of clinically relevant bleeding (hospital admission caused by bleeding) among patients taking warfarin for atrial fibrillation who were concurrently on SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched to randomly chosen patients who received warfarin alone (n=117). The SSRIs included FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleedings over 586.4 treatment years. The corresponding overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. Compared with warfarin alone, the hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009). The SSRIs involved in patients who bled during concurrent use were sertraline or citalopram. Adding an SSRI did not produce a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study findings may be constrained by prior bleeding events, unknown patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids, and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) with concurrent selective serotonin reuptake inhibitors (SSRIs) found an elevated risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, researchers identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also taking a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients taking SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) A non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers evaluated sertraline's effect on the plasma protein binding of warfarin. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or the placebo group; the sertraline dose was progressively raised from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and at intervals afterward. The investigators concluded that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown a link between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events related to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Ardeparin together?
Taking sertraline with the blood thinner ardeparin adds up to a higher bleeding risk, so keep taking both as prescribed but watch for bruising or bleeding and report it to your care team. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Ardeparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Ardeparin interaction managed?
Your care team can manage this combination safely with awareness and monitoring. Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely for bleeding, and your doses may be adjusted and individualized as needed. Watch for and promptly report: nosebleeds, unusual bruising, blood in urine or stool, black stools, coughing or vomiting b… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Ardeparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Ardeparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist